| Not Yet Recruiting | Efficacy and Safety of Triple Therapy With Dulaglutide, SGLT2 Inhibitors, and Finerenone in Chinese Adults Wit NCT07537088 | First Affiliated Hospital of Wannan Medical College | Phase 4 |
| Not Yet Recruiting | A Mechanistic Study on the Effect of HTD1801 Versus Placebo on Kidney Function in Patients With Type 2 Diabete NCT07496177 | Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences | Phase 2 |
| Not Yet Recruiting | The Effect of Alogliptin Combined With Actoplus Met on Glucose and Lipid Metabolism and Pancreatic Function in NCT07289750 | The Fourth Affiliated Hospital of Zhejiang University School of Medicine | Phase 4 |
| Not Yet Recruiting | Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus NCT07527650 | Hanmi Pharmaceutical Company Limited | Phase 2 |
| Not Yet Recruiting | Endocrine Disruption, Menopause, and Poor Sleep in wOmen With Type 2 Diabetes: Effects on Cardiovascular Healt NCT07486986 | Ottawa Heart Institute Research Corporation | — |
| Recruiting | A Single-Center, Open-Label, Single Ascending Dose Study of Exenatide Circular RNA-Lipid Nanoparticle Injectio NCT07347080 | The First Affiliated Hospital of Henan University of Science and Technology | EARLY_Phase 1 |
| Recruiting | Pilot of Continuous Glucose Monitor-Augmented Food Is Medicine NCT07148713 | University of North Carolina, Chapel Hill | N/A |
| Not Yet Recruiting | The Effect of Semaglutide on Bone Health NCT07165158 | The First Affiliated Hospital of Xiamen University | Phase 4 |
| Recruiting | Fitbit and AI Chatbot in Sedentary Primary Care Patients With T2D NCT07005362 | University of Colorado, Denver | — |
| Completed | Detecting Type 2 Diabetes From Voice NCT07421921 | Thymia Limited | — |
| Not Yet Recruiting | A Study of RAY1225 Versus Semaglutide as Add-on Therapy to Oral Antidiabetic Drugs in Participants With Type 2 NCT07139548 | Guangdong Raynovent Biotech Co., Ltd | Phase 3 |
| Not Yet Recruiting | A Study of RAY1225 in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone NCT07139535 | Guangdong Raynovent Biotech Co., Ltd | Phase 3 |
| Recruiting | Cofrogliptin Once Every 2 Weeks as Add-on Therapy to Metformin and Dapagliflozin Versus Daily Linagliptin in P NCT07019012 | Huazhong University of Science and Technology | Phase 4 |
| Recruiting | Efficacy and Safety of Add-On Therapy With Empagliflozin in Patients With Type 2 Diabetes on a Background of A NCT07093476 | Celltrion | Phase 3 |
| Recruiting | Effects of Calcium on Gut Functions and Blood Glucose in Humans With Type 2 Diabetes NCT06942195 | University of Adelaide | N/A |
| Withdrawn | Embecta AID System in Adults With Type 2 Diabetes NCT06692153 | Embecta Corp. | N/A |
| Active Not Recruiting | Efficacy and Safety of Pioglitazone Combination Therapy in Type 2 Diabetes Patients on a Background of Empagli NCT06571591 | Celltrion | Phase 3 |
| Recruiting | Comprehensive Clinical Evaluation Study of GLP-1RA NCT06686134 | LI YAN | — |
| Recruiting | The Intelligent Prevention And Control System And Strategy For The Whole Disease Cycle Of Diabetic Nephropathy NCT06843304 | Chinese PLA General Hospital | — |
| Unknown | A Phase 1 Trial to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-3167 Single I NCT05996380 | Jiangsu HengRui Medicine Co., Ltd. | Phase 1 |
| Completed | Drug-Drug Interaction Study of Chiglitazar in Healthy Subjects. NCT05681273 | Chipscreen Biosciences, Ltd. | Phase 1 |
| Completed | A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Dulaglutide in Participants With T2DM NCT05680129 | Hangzhou Sciwind Biosciences Co., Ltd. | Phase 3 |
| Completed | A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Placebo in T2DM Patients NCT05680155 | Hangzhou Sciwind Biosciences Co., Ltd. | Phase 3 |
| Completed | Hydroxyl Free Radical Associated Effects of SGLT-2 Inhibitors in Type 2 Diabetes NCT06797115 | University of Pecs | — |
| Unknown | Safety and Efficacy of THR-1442 Compared to Dapagliflozin as Add-on Therapy to Metformin in T2DM NCT05159882 | Newsoara Biopharma Co., Ltd. | Phase 3 |
| Unknown | Clinical Trial to Compare the PK of the Fixed-dose Combinations and Each Component of Gemigliptin/Dapagliflozi NCT04544319 | LG Chem | Phase 1 |
| Unknown | Tai Chi for Comorbid Depression in T2DM Patients NCT04609631 | Chengdu University of Traditional Chinese Medicine | N/A |
| Recruiting | Comparing the Efficacy and Safety Between Continuous Subcutaneous Beinaglutide and CSII for Newly Diagnosed T2 NCT03987308 | Beijing Hospital | N/A |
| Unknown | Efficacy and Safety of Vildagliptin Added to Continuous Subcutaneous Insulin Infusion in Uncontrolled Type 2 D NCT03563794 | The First Affiliated Hospital of Xiamen University | Phase 4 |
| Unknown | The Imaging Genetic Study of Type 2 Diabetes and Depression NCT03564431 | Kunming Medical University | — |
| Completed | Efficacy and Safety of Gemigliptin 50mg qd Added in Patients With Type 2 Diabetes Inadequately Controlled on G NCT01990469 | LG Life Sciences | Phase 3 |
| Completed | Metabolic Surgery for Metabolic Syndrome NCT07183137 | The Third Xiangya Hospital of Central South University | — |
| Unknown | Sleep Disordered Breathing and Impaired Glucose Homeostasis in Obese Children NCT02037100 | Tel-Aviv Sourasky Medical Center | — |